SynthesisJournal of clinical laboratory analysis2012

ERCC1 and XPD/ERCC2 polymorphisms' predictive value of oxaliplatin-based chemotherapies in advanced colorectal cancer has an ethnic discrepancy: a meta-analysis.

Xiaobo Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.